DA-1229_01
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DA-1229_01, covering 2014-12-02 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State [Phase 1]